Based on results from the NYS pilot study [7,8], CK-MM levels in newborns can range from less than 100 ng/mL to as high as 19,000 ng/mL depending on post-natal age, birth trauma, and congenital disorders including DMD and other muscular dystrophies. The gene discussed is CKM; the disease is muscular dystrophy.